Rising adoption of AI, IoT, 5G, cloud computing, and real-time applications continues to drive investments in distributed computing infrastructure worldwide.SAN FRANCISCO, June 10, 2026...
Rising adoption of AI, IoT, 5G, cloud computing, and real-time applications continues to drive investments in distributed computing infrastructure worldwide.SAN FRANCISCO, June 10, 2026...
2H26 Spending to Accelerate with NVIDIA Rubin RampREDWOOD CITY, Calif., June 10, 2026 /PRNewswire/ -- According to a recently published report by Dell'Oro Group,...
The dancewear market is witnessing steady adoption across dance academies, professional dance companies, fitness centers, educational institutions, performance arts organizations, and individual consumers due...
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Jewelry Market size & share revenue was valued at approximately USD 382 Billion in 2025 and is expected to reach USD 403 Billion in 2026 and is expected to reach around USD 659 Billion by 2035, at a CAGR of 5.6% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Harry Winston, Dora International, Malabar Gold & Diamonds, Pandora, Louis Vuitton SE, Chow Tai Fook, GRAFF, Richemont, Signet Jewelers Ltd., H. Stern, Swarovski AG, Damiani, Blue Nile, Buccellati, De Beers, Jacob & Co., Tiffany & Co., Fame Diamonds, Gemco Designs, Mauboussin and others.
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Jewelry Market size & share revenue was valued at approximately USD 382 Billion in 2025 and is expected to reach USD 403 Billion in 2026 and is expected to reach around USD 659 Billion by 2035, at a CAGR of 5.6% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Harry Winston, Dora International, Malabar Gold & Diamonds, Pandora, Louis Vuitton SE, Chow Tai Fook, GRAFF, Richemont, Signet Jewelers Ltd., H. Stern, Swarovski AG, Damiani, Blue Nile, Buccellati, De Beers, Jacob & Co., Tiffany & Co., Fame Diamonds, Gemco Designs, Mauboussin and others.
LONDON, June 9, 2026 /PRNewswire/ -- Persistence Market Research, a leading management consulting firm, has released this update on the data center liquid cooling market....
LONDON, June 9, 2026 /PRNewswire/ -- Persistence Market Research, a leading management consulting firm, has released this update on the data center liquid cooling market....
AI Security Threat Reinforces Cisco's Refresh StrategyREDWOOD CITY, Calif., June 9, 2026 /PRNewswire/ -- According to a recently published report from Dell'Oro Group, the trusted...
DELRAY BEACH, Fla., June 9, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the EV Battery Market is projected to reach USD 168.95 billion by 2035, from USD...
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Generic Drug Market size & share revenue was valued at approximately USD 491.35 Billion in 2024 and is expected to reach USD 519.11 Billion in 2025 and is expected to reach around USD 926.54 Billion by 2034, at a CAGR of 6.55% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Alkem Laboratories Limited, Teva Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., Lupin Limited, STADA Arzneimittel AG, Hikma Pharmaceuticals plc, Torrent Pharmaceuticals Ltd., Endo International plc, Aurobindo Pharma Limited, Sawai Pharmaceutical Co. Ltd., Mallinckrodt plc, Amneal Pharmaceuticals Inc and others.
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Generic Drug Market size & share revenue was valued at approximately USD 491.35 Billion in 2024 and is expected to reach USD 519.11 Billion in 2025 and is expected to reach around USD 926.54 Billion by 2034, at a CAGR of 6.55% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Alkem Laboratories Limited, Teva Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., Lupin Limited, STADA Arzneimittel AG, Hikma Pharmaceuticals plc, Torrent Pharmaceuticals Ltd., Endo International plc, Aurobindo Pharma Limited, Sawai Pharmaceutical Co. Ltd., Mallinckrodt plc, Amneal Pharmaceuticals Inc and others.